Moving Analytics Chosen for HealthTech Arkansas Cohort of 5

Home » Blog » Moving Analytics Chosen for HealthTech Arkansas Cohort of 5

Moving Analytics is a Rosenman Innovator company. From Talk Business & Politics

Startup incubator and new business accelerator HealthTech Arkansas has selected five new companies to participate in its next cohort that launches on Nov. 2.

For the 2021 program, the HealthTech Arkansas accelerator is focused exclusively on companies delivering cardiovascular technologies, such as devices, digital health and diagnostics, or innovations that can be targeted primarily to cardiac patient populations, such as remote patient monitoring. Only applications from companies that met these criteria were considered.

“Focusing only on cardiovascular technologies concentrates our efforts on a clinical area that’s important to the state of Arkansas and gives us the best opportunity to improve clinical outcomes in our state,” said Jeff Stinson, Director of HealthTech Arkansas.

The five companies selected are:

Hi-D Imaging, Zurich, Switzerland
Hi-D Imaging is an AI imaging software that improves clinical outcomes and decreases pre-operational planning time by providing personalized solutions based on each patient’s anatomy.

Moving Analytics, Irvine, CA
Moving Analytics is a virtual cardiac rehab platform that boosts hospital revenues, improves clinical outcomes, and reduces readmissions — even for those hospitals that have existing cardiac rehabilitation programs.

Lumi Health, Washington, DC
Lumi Health is a remote patient monitoring solution that is AI-driven to better manage medications for heart failure patients, coupled with devices that collect patient biomarkers and an interdisciplinary team that interfaces with patients at home.

SoniVie, Tel Aviv, Israel
SoniVie is a proprietary intravascular denervation system using unfocused ultrasound that gives deeper penetration to treat more nerves than competitive RF and other ultrasound-based catheters. The target of their ongoing clinical studies is patients with uncontrolled and resistant hypertension.

Genetesis, Mason, OH
Genetesis is an FDA-cleared biomagnetic imaging solution that can detect myocardial ischemia in patients with chest pain and other anginal equivalents.

The cohort will participate in a program that provides them the opportunity to build solutions specifically identified by Arkansas Children’s Hospital, Arkansas Heart Hospital, Arkansas Urology, Baptist Health, CHI St. Vincent, Conway Regional Health System, Mercy, Northwest Health, OrthoArkansas, St. Bernards Healthcare, University of Arkansas for Medical Sciences (UAMS), and Washington Regional Medical Center.

Each company will receive seed investment as well as access to clinicians and administrators while executing their pilot projects.

“Over the past three years, working with HealthTech Arkansas to introduce new healthcare technologies to our hospital and to our state has been beneficial not only to our patients but to our staff. We get a chance to see the latest medical innovations, and it helps our own staff to think more innovatively, as well,” said Dr. Gerry Jones, Chief Medical Officer at CHI St. Vincent.

HealthTech Arkansas is a fourth-year accelerator program.